Question 1

What is Genesis Therapeutics' main focus?

Accepted Answer

Genesis develops industry-leading molecular AI to unlock tough protein targets and invent small-molecule medicines with unprecedented potency and selectivity.

Question 2

What is the GEMS platform?

Accepted Answer

GEMS is Genesis’ proprietary AI platform that synthesizes AI and physics research to find drug candidates against difficult targets with industry-leading speed, potency, and selectivity.

Question 3

What is Pearl?

Accepted Answer

Pearl is Genesis’ proprietary foundation model for protein–ligand structure prediction, reported to outperform frontier models like AlphaFold 3 on key benchmarks.

Question 4

When was Genesis founded, and what is its funding history?

Accepted Answer

Founded in 2019, Genesis raised a $4.1M seed (a16z), a $52M Series A (2020, Rock Springs Capital), and a $200M oversubscribed Series B (2023, co-led by a16z with investors including Fidelity, BlackRock, and NVIDIA).

Question 5

Who leads Genesis Therapeutics?

Accepted Answer

CEO and co-founder Evan Feinberg, Ph.D.; COO Will McCarthy; and CSO Shifeng Pan, Ph.D., a veteran drug developer with FDA-approved programs.

Question 6

What does Genesis’ pipeline involve?

Accepted Answer

AI-enabled small-molecule drug candidates with high potency and selectivity for chemically complex targets, spanning multiple therapeutic areas such as immunology and inflammation.

Question 7

What recent collaborations has Genesis announced?

Accepted Answer

Genesis announced a strategic AI-focused research collaboration with Incyte to leverage GEMS for discovering breakthrough small-molecule therapeutics.

Question 8

Where is Genesis headquartered?

Accepted Answer

Genesis is headquartered in San Diego, where its team of chemists and biologists deploys GEMS to progress the internal pipeline.

Question 9

How does GEMS combine AI and physics-based machine learning?

Accepted Answer

GEMS integrates deep learning with physics-informed models to predict protein–ligand interactions and guide design toward potent, selective small molecules.

Question 10

Which therapeutic areas does Genesis target?

Accepted Answer

Genesis applies its platform across multiple disease areas, including immunology and inflammation, while pursuing additional areas with high unmet need.

Question 11